Form 4 for MCRB Seres Therapeutics, Inc.
Accepted 2024-10-29 00:00:00 ET · period of report 2024-10-27 · accession 0000950170-24-118418 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-10-29 | 2024-10-28 | MCRB | Henn Matthew R. | See Remarks | S - Sale+OE | $0.69 | -3,984 | 75.9K | -5% | -$2,749 |
| DT | 2024-10-29 | 2024-10-27 | MCRB | Henn Matthew R. | See Remarks | M - OptEx | $0.00 | +12.6K | 79.9K | +19% | $0 |
| DT | 2024-10-29 | 2024-10-27 | MCRB | Henn Matthew R. | See Remarks | M - OptEx | $0.00 | -12.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-28 | S | D | 3,984 | $0.69 | 75,885 | D | — | — | (F4) The price reported in column 4 is a weighted average of the sale prices. These shares were sold in multiple transactions at prices ranging from $0.69 to $ 0.69605, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-10-27 | M | A | 12,622 | $0.00 | 79,869 | D | — | — | (F2) Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs do not have an expiration date. |
| 3 | Derivative | Restricted Stock Units | 2024-10-27 | M | D | 12,622 | $0.00 | 0 | D | — · — to — | 12,622 Common Stock | (F2) Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs do not have an expiration date. (F1) On February 3, 2023, the reporting person was granted an award of 25,245 restricted stock units ("RSUs"), which vest in the form of shares of the Issuer's common stock in two substantially equal installments upon the satisfaction of certain performance criteria. On April 27, 2023 (the "Initial Milestone Date"), the Issuer's Administrator determined that the performance criteria for the first installment were met, resulting in the vesting and settlement of the award as to 12,623 RSUs on October 27, 2023, the date that was six months from the Initial Milestone Date. The remaining 12,622 RSUs vested and settled on October 27, 2024, the date that was eighteen months from the Initial Milestone Date. |